Author: Tsutsué, Saaya; Makita, Shinichi; Yi, Jingbo; Crawford, Bruce
Title: Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma Cord-id: 1d9uw1t0 Document date: 2021_8_20
ID: 1d9uw1t0
Snippet: Aim: To understand the economic burden of relapsed and refractory large B-cell lymphoma patients in Japan treated with salvage chemotherapy. Patients & methods: Patients who received systemic therapy after first-line treatment were analyzed to assess its associated cost and resource use using a retrospective claims database. The impact of COVID-19 was assessed separately. Results & conclusion: This study identified 2927 and 1085 patients in the second- (2L) and third-line (3L) cohorts. The media
Document: Aim: To understand the economic burden of relapsed and refractory large B-cell lymphoma patients in Japan treated with salvage chemotherapy. Patients & methods: Patients who received systemic therapy after first-line treatment were analyzed to assess its associated cost and resource use using a retrospective claims database. The impact of COVID-19 was assessed separately. Results & conclusion: This study identified 2927 and 1085 patients in the second- (2L) and third-line (3L) cohorts. The median ages for the 2L and 3L cohorts were 71 and 70 years, respectively, with Charlson Comorbidity Score of 3. A majority of the patients had limited stem cell transplant due to advanced age. Median lengths of inpatient stay for the 2L and 3L cohorts were 118 and 116 days, respectively. The majority of costs were attributed to inpatient costs, and limited COVID-19 impact was observed in this study.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and acute phase: 1
- absolute lymphocyte count and admission patient: 1, 2
- absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- active treatment and acute hospital: 1, 2, 3
- active treatment and acute phase: 1, 2, 3, 4
- active treatment and admission patient: 1, 2, 3, 4, 5
- active treatment and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
- active treatment and lymphoma active treatment: 1, 2, 3
- active treatment and lymphoma patient: 1, 2
- acute hospital and admission patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute hospital and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase and admission patient: 1, 2, 3
- acute phase and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- addition prior and admission patient: 1
Co phrase search for related documents, hyperlinks ordered by date